
Our response to cancer always starts with the science
Targeting cancer demands a deep understanding of its complexities. Our researchers have the freedom to explore cutting-edge science & technology to achieve this.
moreOur scientists take a rigorous, comprehensive approach to understanding cancer biology and drug discovery.
Targeting cancer demands a deep understanding of its complexities. Our researchers have the freedom to explore cutting-edge science & technology to achieve this.
moreThe evolution of cancer care has transformed outcomes to the extent some are described as potentially curable. Our goal is to bring this benefit to all patients.
moreWe remain committed to finding new ways to tackle the disease with the goal of improving patient outcomes and bringing them closer to cure.
moreDespite treatments improving in the early lines of therapy, in advanced colorectal cancer options remain limited.
moreHCC is known as a ‘silent killer’ as the symptoms often appear too late for curative treatments. Learn more about the signs, symptoms and risk factors.
more